GlassScriptPhysician profile
Perry A Shear
NPI 1821009853
$3,820.37
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $20.61 · 2022: $2,813 · 2023: $507 · 2024: $59.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.37 |
| Education | $100.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $2,919.68 | 2019-2022 | |
| Zimvie INC. | $342.85 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $124.54 | 2019 | |
| Stryker Corporation | $115.32 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $100.08 | 2023 | |
| Depuy Synthes Sales INC. | $90.14 | 2023 | Symphony, Viper, Expedium Verse |
| Orthofix Medical, INC. | $45.07 | 2019 | |
| Highridge Medical LLC | $33.38 | 2024 | Spf Xl Iib Implantable Spinal Fusion Stimulator, Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Medtronic USA, INC. | $20.61 | 2020 | |
| Abbott Laboratories | $17.29 | 2019 | |
| Dynasplint Systems INC. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perry Shear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.